Enoxaparin how supplied storage and handling

Revision as of 05:36, 6 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Enoxaparin}} {{CMG}}; {{AE}} {{SS}} ==How Supplied Storage And Handling== {| |- |thumb|800px |- |} Store at 25°C (77°F); excursions pe...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Enoxaparin
LOVENOX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Enoxaparin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

How Supplied Storage And Handling

Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature].

Do not store the multiple-dose vials for more than 28 days after the first use.[1]

References

  1. "LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC]". Retrieved 6 February 2014.

Template:WikiDoc Sources